Skip to main content
Clinical Trials/NCT02434159
NCT02434159UnknownNot Applicable

Role of Cardiac Computed Tomography and Cardiac Magnetic Resonance in Optimising Response to Cardiac Resynchronisation Therapy

University College, London1 site in 1 country100 target enrollmentStarted: May 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
100
Locations
1
Primary Endpoint
6 minute walk test

Study Overview

Brief Summary

The purpose of this study is to determine if detailed scanning of the heart before biventricular device insertion will improve outcomes for heart failure patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age > 18, <90
  • Patients with moderate or severe heart failure ( NYHA functional class II-IV) due to ischaemic or non-ischaemic cardiomyopathy.
  • QRS duration >120ms on 12 lead ECG
  • LVEF < 35%
  • LVEDD >55 mm
  • Patients on optimum medical treatment for heart failure. The doses of these medications have been stable for 3 months.

Exclusion Criteria

  • Patients with a cardiac or cerebral ischemic event within the previous three months prior to recruitment
  • Patients who had had an atrial arrhythmia within one month prior to recruitment
  • Patients with a systolic blood pressure of more than 170 or less than 80 mm Hg
  • Patients with a heart rate of more than 140 beats per minute
  • Patients with severe renal failure (eGFR < 30)
  • Patients with a history of allergy to iodine based contrast agents
  • Predicted life expectancy < 1 year

Arms & Interventions

Scan

Active Comparator

Heart scan prior to device insertion

Intervention: Heart scan (Other)

No scan

No Intervention

No heart scan prior to device insertion

Outcomes

Primary Outcomes

6 minute walk test

Time Frame: 6 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials